Spruce Biosciences, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -38.0% | -36.4% | -33.4% |
| FY2022 | -67.4% | -64.3% | -53.9% |
| FY2023 | -62.6% | -61.3% | -46.1% |
| FY2024 | -184.0% | -183.2% | -117.3% |
| FY2025 | -91.7% | -91.7% | -73.5% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -38.0% | -36.4% | -33.4% |
| FY2022 | -67.4% | -64.3% | -53.9% |
| FY2023 | -62.6% | -61.3% | -46.1% |
| FY2024 | -184.0% | -183.2% | -117.3% |
| FY2025 | -91.7% | -91.7% | -73.5% |